TPN-101

· Transposon Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TPN-101, covering 2026-04-03 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) [Phase 2]